Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|77|1|50-56

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.77, Iss.1, 2009-05, pp. : 50-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strontium-89 Chloride in the Treatment of Bone Metastases from Breast Cancer

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 377-381

Karger

Access to resources Recommend Favorite

Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 78, Iss. 1, 2007-01 ,pp. : 50-57

Karger

Access to resources Recommend Favorite

Diagnostic Value of Serum Ghrelin Levels in Prostate Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 3, 2008-05 ,pp. : 245-248

Karger

Access to resources Recommend Favorite

Serum Adipocytokine Levels in Prostate Cancer Patients

By  

Urologia Internationalis, Vol. 82, Iss. 2, 2009-03 ,pp. : 203-208

Karger

Access to resources Recommend Favorite

Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 345-350

Karger

Access to resources Recommend Favorite